Skip to main content
Erschienen in: Journal of General Internal Medicine 3/2020

16.07.2019 | Concise Research Report

Patient Perspectives on Primary HPV Testing for Routine Cervical Cancer Screening

verfasst von: Shannon N. Ogden, MPH, Karen Glanz, PhD, MPH, Marilyn M. Schapira, MD, MPH, Claire Bocage, BA, Whitney Eriksen, PhD, RN, Katharine A. Rendle, PhD, MSW, MPH

Erschienen in: Journal of General Internal Medicine | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Excerpt

Driven by advances in screening technologies and an increased understanding of the natural history of cervical cancer, routine cervical cancer screening guidelines have changed from annual screening with cytology to less frequent screening using cytology alone triennially or in conjunction with high-risk human papillomavirus (HPV) testing every 5 years.1 In August 2018, the United States Preventive Services Task Force (USPSTF) released updated screening recommendations, which added the option for women aged 30–65 to be screened every 5 years with primary HPV testing alone2 and further solidified interim guidance on primary HPV testing released in 2015.3 Previous studies have shown patient concerns regarding HPV testing prior to the new guidelines.4, 5 We assessed women’s perspectives on primary HPV testing following the release of 2018 USPSTF recommendations. …
Literatur
1.
Zurück zum Zitat Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol. 2012;137(4):516–542.CrossRef Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol. 2012;137(4):516–542.CrossRef
2.
Zurück zum Zitat US Preventive Services Task Force. Screening for cervical cancer: US Preventive Services Task Force recommendation statement. JAMA. 2018;320(7):674–686.CrossRef US Preventive Services Task Force. Screening for cervical cancer: US Preventive Services Task Force recommendation statement. JAMA. 2018;320(7):674–686.CrossRef
3.
Zurück zum Zitat Huh WK, Ault KA, Chelmow D, et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Obstet Gynecol. 2015;125(2):330–337.CrossRef Huh WK, Ault KA, Chelmow D, et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Obstet Gynecol. 2015;125(2):330–337.CrossRef
4.
Zurück zum Zitat Gerend MA, Shepherd MA, Kaltz EA, Davis WJ, Shepherd JE. Understanding women’s hesitancy to undergo less frequent cervical cancer screening. Prev Med. 2017;95:96–102.CrossRef Gerend MA, Shepherd MA, Kaltz EA, Davis WJ, Shepherd JE. Understanding women’s hesitancy to undergo less frequent cervical cancer screening. Prev Med. 2017;95:96–102.CrossRef
5.
Zurück zum Zitat Silver MI, Rositch AF, Burke AE, Chang K, Viscidi R, Gravitt PE. Patient concerns about human papillomavirus testing and 5-year intervals in routine cervical cancer screening. Obstet Gynecol. 2015;125(2):317–329.CrossRef Silver MI, Rositch AF, Burke AE, Chang K, Viscidi R, Gravitt PE. Patient concerns about human papillomavirus testing and 5-year intervals in routine cervical cancer screening. Obstet Gynecol. 2015;125(2):317–329.CrossRef
6.
Zurück zum Zitat Creswell J, Poth C. Qualitative inquiry and research design: Choosing among five traditions. 4th ed. Thousand Oaks, CA: Sage; 2018. Creswell J, Poth C. Qualitative inquiry and research design: Choosing among five traditions. 4th ed. Thousand Oaks, CA: Sage; 2018.
Metadaten
Titel
Patient Perspectives on Primary HPV Testing for Routine Cervical Cancer Screening
verfasst von
Shannon N. Ogden, MPH
Karen Glanz, PhD, MPH
Marilyn M. Schapira, MD, MPH
Claire Bocage, BA
Whitney Eriksen, PhD, RN
Katharine A. Rendle, PhD, MSW, MPH
Publikationsdatum
16.07.2019
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe 3/2020
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05175-4

Weitere Artikel der Ausgabe 3/2020

Journal of General Internal Medicine 3/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.